These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 743652)

  • 1. Alterations of membrane phosphorylation in erythrocyte membranes from patients with Duchenne muscular dystrophy.
    Vickers JD; McComas AJ; Rathbone MP
    Can J Neurol Sci; 1978 Nov; 5(4):437-42. PubMed ID: 743652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte spectrin peak II phosphorylation in Duchenne muscular dystrophy.
    Roses AD; Appel SH
    J Neurol Sci; 1976 Oct; 29(2-4):185-93. PubMed ID: 978207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myotonic muscular dystrophy: abnormal temperature response of membrane phosphorylation in erythrocyte membranes.
    Vickers JD; McComas AJ; Rathbone MP
    Neurology; 1979 Jun; 29(6):791-6. PubMed ID: 221855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrin extractability from erythrocyte in Duchenne muscular dystrophies and the effect of proteases on erythrocyte ghosts.
    Tsuchiya Y; Sugita H; Ishiura S; Imahori K
    Clin Chim Acta; 1981 Feb; 109(3):285-93. PubMed ID: 6452973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased phosphorylated components of erythrocyte membrane spectrin band II with reference to Duchenne muscular dystrophy.
    Roses AD; Herbstreith M; Metcalf B; Appel SH
    J Neurol Sci; 1976 Nov; 30(1):167-78. PubMed ID: 10352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered erythrocyte spectrin extractability in Duchenne muscular dystrophy.
    Nagano Y; Wong P; Roses AD
    Clin Chim Acta; 1980 Dec; 108(3):469-74. PubMed ID: 7471477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of abnormally [32P]-phosphorylated cyanogen bromide cleavage product of erythrocyte membrane spectrin in Duchenne muscular dystrophy.
    Roses AD; Shile PE; Herbstreith MH; Balakrishnan CV
    Neurology; 1981 Aug; 31(8):1026-30. PubMed ID: 7196515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrin extractability from erythrocytes in Duchenne muscular dystrophy patients and carriers and in other myopathies.
    Gargioni G; Chiaffoni G; Bonadonna G; Corradini P; Lechi C; de Grandis D; Zatti M
    Clin Chim Acta; 1985 Feb; 145(3):259-65. PubMed ID: 3987029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte membrane protein kinase and adenylate cyclase in Duchenne muscular dystrophy.
    Tortolero M; Fischer S; Piau JP; Delaunay J; Schapira G
    Biomedicine; 1979 Feb; 30(1):47-52. PubMed ID: 223680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase and adenylate cyclase of erythrocyte membrane from patients with Duchenne muscular dystrophy.
    Fischer S; Tortolero M; Piau JP; Delaunay J; Schapira G
    Clin Chim Acta; 1978 Sep; 88(3):437-40. PubMed ID: 699336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte spectrofluorometric abnormalities in Duchenne patients and carriers. A new approach to carrier detection.
    Scarlato G; Meola G; Silani V; Manfredi L; Bottiroli G; Zanella A
    Acta Neurol Scand; 1979 May; 59(5):262-9. PubMed ID: 474067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of component a of the human erythrocyte membrane in myotonic muscular dystrophy.
    Roses AD; Appel SH
    J Membr Biol; 1975; 20(1-2):51-8. PubMed ID: 123592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipids and proteins of erythrocyte membrane in Duchenne muscular dystrophy.
    Kobayashi T; Mawatari S; Kuroiwa Y
    Clin Chim Acta; 1978 May; 85(3):259-66. PubMed ID: 657522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of erythrocyte ghost protein phosphorylation in the Duchenne and myotonic muscular dystrophies.
    Vickers JD; Rathbone MP; Roses AD
    Biochem Med; 1978 Dec; 20(3):434-9. PubMed ID: 752350
    [No Abstract]   [Full Text] [Related]  

  • 15. Red cell membrane protein phosphorylation in hemolytic anemias and muscular dystrophies.
    Tsung PK; Palek J
    Muscle Nerve; 1980; 3(1):55-69. PubMed ID: 6246419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased [32P]-phosphorylation of tryptic peptides of erythrocyte spectrin in Duchenne muscular dystrophy.
    Mabry ME; Roses AD
    Muscle Nerve; 1981; 4(6):489-93. PubMed ID: 7311988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical compositional studies of erythrocyte membranes in Duchenne muscular dystrophy.
    Godin DV; Bridges MA; MacLeod PJ
    Res Commun Chem Pathol Pharmacol; 1978 May; 20(2):331-49. PubMed ID: 674819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A spin label study of the erythrocyte membranes in Duchenne muscular dystrophy.
    Laurent M; Daveloose D; Leterrier F; Fischer S; Schapira G
    Clin Chim Acta; 1980 Aug; 105(2):183-94. PubMed ID: 6249518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythrocyte cation-activated adenosine triphosphatases in Duchenne muscular dystrophy.
    Hodson A; Pleasure D
    J Neurol Sci; 1977 Jul; 32(3):361-9. PubMed ID: 142127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte-ghost Ca2+-stimulated Mg2+-dependent adenosine triphosphatase in Duchenne muscular dystrophy.
    Dunn MJ; Burghes AH; Dubowitz V
    Biochem J; 1982 Mar; 201(3):445-53. PubMed ID: 6124239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.